TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharma Systems AB
Closing information (x1000 DKK)
| Closing information | 2024/06 (consolidated) | 2023/06 (consolidated) | 2021/12 |
| Turnover |
13,958
|
22,951
|
20,561 |
| Financial expenses |
162
|
136
|
4 |
| Earnings before taxes |
-2,189
|
217
|
2,930 |
| EBITDA |
-1,489
|
1,489
|
3,122 |
| Total assets |
15,326
|
14,428
|
23,716 |
| Current assets |
11,004
|
9,519
|
20,958 |
| Current liabilities |
3,916
|
2,439
|
3,035 |
| Equity capital |
9,370
|
9,016
|
17,723 |
| - share capital |
135
|
130
|
150 |
| Employees (average) |
29
|
34
|
2 |
Financial ratios
| Fiscal year | 2024/06 (consolidated) | 2023/06 (consolidated) | 2021/12 |
| Solvency |
61.1%
|
62.5%
|
74.7% |
| Turnover per employee |
481
|
675
|
10,280 |
| Profit as a percentage of turnover |
-15.7%
|
0.9%
|
14.3% |
| Return on assets (ROA) |
-13.2%
|
2.4%
|
12.4% |
| Current ratio |
281.0%
|
390.3%
|
690.5% |
| Return on equity (ROE) |
-23.4%
|
2.4%
|
16.5% |
| Change turnover |
-9,901
|
5,093
|
-6,343 |
| Change turnover % | -41% | -24% | |
| Chg. No. of employees |
-5
|
32
|
0 |
| Chg. No. of employees % | -15% | 0% |
Total value of public sale
| Fiscal year | 2024/06 (consolidated) | 2023/06 (consolidated) | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.